11 results on '"Bortoli, N."'
Search Results
2. Six-Food Elimination Diet Is Less Effective During Pollen Season in Adults With Eosinophilic Esophagitis Sensitized to Pollens.
- Author
-
Visaggi P, Savarino E, Del Corso G, Hunter H, Baiano Svizzero F, Till SJ, Dunn J, Wong T, de Bortoli N, and Zeki S
- Subjects
- Humans, Adult, Elimination Diets, Seasons, Food, Pollen, Eosinophilic Esophagitis therapy
- Abstract
Introduction: The role of inhaled and swallowed aeroallergens in treatment outcomes of adult patients with eosinophilic esophagitis (EoE) is unclear. We hypothesized that the pollen season contributes to the failure of the 6-food elimination diet (SFED) in EoE., Methods: We compared outcomes of patients with EoE who underwent SFED during vs outside of the pollen season. Consecutive adult patients with EoE who underwent SFED and skin prick test (SPT) for birch and grass pollen were included. Individual pollen sensitization and pollen count data were analyzed to define whether each patient had been assessed during or outside of the pollen season after SFED. All patients had active EoE (≥15 eosinophils/high-power field) before SFED and adhered to the diet under the supervision of a dietitian., Results: Fifty-eight patients were included, 62.0% had positive SPT for birch and/or grass, whereas 37.9% had negative SPT. Overall, SFED response was 56.9% (95% confidence interval, 44.1%-68.8%). When stratifying response according to whether the assessment had been performed during or outside of the pollen season, patients sensitized to pollens showed significantly lower response to SFED during compared with outside of the pollen season (21.4% vs 77.3%; P = 0.003). In addition, during the pollen season, patients with pollen sensitization had significantly lower response to SFED compared with those without sensitization (21.4% vs 77.8%; P = 0.01)., Discussion: Pollens may have a role in sustaining esophageal eosinophilia in sensitized adults with EoE despite avoidance of trigger foods. The SPT for pollens may identify patients less likely to respond to the diet during the pollen season., (Copyright © 2023 by The American College of Gastroenterology.)
- Published
- 2023
- Full Text
- View/download PDF
3. Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease.
- Author
-
Visaggi P, Del Corso G, Gyawali CP, Ghisa M, Baiano Svizzero F, Stefani Donati D, Venturini A, Savarino V, Penagini R, Zeki S, Bellini M, Savarino EV, and de Bortoli N
- Subjects
- Humans, Electric Impedance, Proton Pump Inhibitors therapeutic use, Esophageal pH Monitoring, Hydrogen-Ion Concentration, Gastroesophageal Reflux drug therapy, Esophagitis complications
- Abstract
Introduction: The Lyon Consensus designates Los Angeles (LA) grade C/D esophagitis or acid exposure time (AET) >6% on impedance-pH monitoring (MII-pH) as conclusive for gastroesophageal reflux disease (GERD). We aimed to evaluate proportions with objective GERD among symptomatic patients with LA grade A, B, and C esophagitis on endoscopy., Methods: Demographics, clinical data, endoscopy findings, and objective proton-pump inhibitor response were collected from symptomatic prospectively enrolled patients from 2 referral centers. Off-therapy MII-pH parameters included AET, number of reflux episodes, mean nocturnal baseline impedance, and postreflux swallow-induced peristaltic wave index. Objective GERD evidence was compared between LA grades., Results: Of 155 patients (LA grade A: 74 patients, B: 61 patients, and C: 20 patients), demographics and presentation were similar across LA grades. AET >6% was seen in 1.4%, 52.5%, and 75%, respectively, in LA grades A, B, and C. Using additional MII-pH metrics, an additional 16.2% with LA grade A and 47.5% with LA grade B esophagitis had AET 4%-6% with low mean nocturnal baseline impedance and postreflux swallow-induced peristaltic wave index; there were no additional gains using the number of reflux episodes or symptom-reflux association metrics. Compared with LA grade C (100% conclusive GERD based on endoscopic findings), 100% of LA grade B esophagitis also had objective GERD but only 17.6% with LA grade A esophagitis ( P < 0.001 compared with each). Proton-pump inhibitor response was comparable between LA grades B and C (74% and 70%, respectively) but low in LA grade A (39%, P < 0.001)., Discussion: Grade B esophagitis indicates an objective diagnosis of GERD., (Copyright © 2023 by The American College of Gastroenterology.)
- Published
- 2023
- Full Text
- View/download PDF
4. Efficacy of a Second PPI Course After Steroid-Induced Remission in Eosinophilic Esophagitis Refractory to Initial PPI Therapy.
- Author
-
Visaggi P, Baiano Svizzero F, Del Corso G, Bellini M, Savarino E, and de Bortoli N
- Subjects
- Enteritis, Eosinophilia, Gastritis, Humans, Proton Pump Inhibitors therapeutic use, Retrospective Studies, Steroids therapeutic use, Eosinophilic Esophagitis drug therapy
- Abstract
Introduction: Eosinophilic esophagitis (EoE) requires maintenance therapy to avoid recurrence. We investigated the efficacy of a second course of proton pump inhibitors (scPPIs) to maintain steroid-induced histological remission (HR) in patients with EoE who had previously failed induction of remission with PPIs., Methods: We retrospectively included 18 patients who achieved HR with topical steroids but could not be maintained on long-term topical steroids. Treatment outcomes were assessed after 12 weeks of scPPIs., Results: Most of the patients (67%) maintained HR with high-dose PPI monotherapy at week 12., Discussion: scPPIs might work as a maintenance strategy in primary PPI nonresponder EoE patients., (Copyright © 2022 by The American College of Gastroenterology.)
- Published
- 2022
- Full Text
- View/download PDF
5. Hypercontractile Esophagus From Pathophysiology to Management: Proceedings of the Pisa Symposium.
- Author
-
de Bortoli N, Gyawali PC, Roman S, Tolone S, Sifrim D, Tutuian R, Penagini R, Pandolfino JE, and Savarino EV
- Subjects
- Acetylcholine Release Inhibitors therapeutic use, Barium Compounds, Botulinum Toxins therapeutic use, Calcium Channel Blockers therapeutic use, Chest Pain physiopathology, Deglutition Disorders physiopathology, Dilatation, Endoscopy, Digestive System, Esophageal Motility Disorders diagnosis, Esophageal Motility Disorders therapy, Esophagogastric Junction physiopathology, Esophagogastric Junction surgery, Heller Myotomy, Humans, Laparoscopy, Manometry, Myotomy, Nitrates therapeutic use, Phosphodiesterase Inhibitors therapeutic use, Pressure, Proton Pump Inhibitors therapeutic use, Radiography, Esophageal Motility Disorders physiopathology, Muscle Contraction physiology, Peristalsis physiology
- Abstract
Hypercontractile esophagus (HE) is a heterogeneous major motility disorder diagnosed when ≥20% hypercontractile peristaltic sequences (distal contractile integral >8,000 mm Hg*s*cm) are present within the context of normal lower esophageal sphincter (LES) relaxation (integrated relaxation pressure < upper limit of normal) on esophageal high-resolution manometry (HRM). HE can manifest with dysphagia and chest pain, with unclear mechanisms of symptom generation. The pathophysiology of HE may entail an excessive cholinergic drive with temporal asynchrony of circular and longitudinal muscle contractions; provocative testing during HRM has also demonstrated abnormal inhibition. Hypercontractility can be limited to the esophageal body or can include the LES; rarely, the process is limited to the LES. Hypercontractility can sometimes be associated with esophagogastric junction (EGJ) outflow obstruction and increased muscle thickness. Provocative tests during HRM can increase detection of HE, reproduce symptoms, and predict delayed esophageal emptying. Regarding therapy, an empiric trial of a proton pump inhibitor, should be first considered, given the overlap with gastroesophageal reflux disease. Calcium channel blockers, nitrates, and phosphodiesterase inhibitors have been used to reduce contraction vigor but with suboptimal symptomatic response. Endoscopic treatment with botulinum toxin injection or pneumatic dilation is associated with variable response. Per-oral endoscopic myotomy may be superior to laparoscopic Heller myotomy in relieving dysphagia, but available data are scant. The presence of EGJ outflow obstruction in HE discriminates a subset of patients who may benefit from endoscopic treatment targeting the EGJ., (Copyright © 2020 by The American College of Gastroenterology.)
- Published
- 2021
- Full Text
- View/download PDF
6. Role of Reflux in the Pathogenesis of Eosinophilic Esophagitis: Comprehensive Appraisal With Off- and On PPI Impedance-pH Monitoring.
- Author
-
Frazzoni M, Penagini R, Frazzoni L, de Bortoli N, Mauro A, Tolone S, Bertani H, Marsico M, Marocchi M, Marchi S, Conigliaro R, and Savarino E
- Subjects
- Adult, Drug Resistance, Electric Impedance, Eosinophilic Esophagitis diagnosis, Eosinophilic Esophagitis pathology, Esophagoscopy, Esophagus diagnostic imaging, Esophagus drug effects, Esophagus pathology, Feasibility Studies, Female, Gastroesophageal Reflux complications, Gastroesophageal Reflux diagnosis, Humans, Male, Middle Aged, Prospective Studies, Proton Pump Inhibitors therapeutic use, Treatment Outcome, Young Adult, Eosinophilic Esophagitis prevention & control, Esophageal pH Monitoring, Gastroesophageal Reflux drug therapy, Proton Pump Inhibitors pharmacology
- Abstract
Objectives: Role of reflux and mechanisms of response to proton pump inhibitor (PPI) therapy in eosinophilic esophagitis (EoE) have not yet been fully elucidated. Comprehensive assessment by impedance-pH monitoring could clarify these issues., Methods: Prospective multicenter study comparing EoE patients with healthy controls and gastroesophageal reflux disease cases. Patients with EoE were evaluated off- and on PPI; responsiveness was assessed by histology. Impedance-pH appraisal included chemical clearance, assessed with the postreflux swallow-induced peristaltic wave (PSPW) index, and mucosal integrity measured with mean nocturnal baseline impedance (MNBI)., Results: Sixty consecutive patients with EoE were compared with 60 age- and sex-matched healthy controls and 60 subjects with gastroesophageal reflux disease. The number of total refluxes was higher, while the PSPW index was lower in patients with EoE than in healthy controls. Off PPI, a lower MNBI gradient between the mid and distal esophagus distinguished 20 patients with PPI-refractory EoE from 40 patients with PPI-responsive EoE and was a predictor of PPI failure. On PPI, a lower PSPW index was the sole reflux parameter distinguishing PPI-refractory from PPI-responsive EoE; all reflux parameters improved in PPI-responsive patients, whereas the PSPW index was not modified in PPI-refractory cases and was independently associated with PPI-responsiveness. MNBI in the distal and mid esophagus improved much more in PPI-responsive than in PPI-refractory EoE., Discussion: Reflux plays a role in the pathogenesis of EoE, more relevant in PPI-responsive cases. Low impedance gradient between the mid and distal esophagus may be useful to predict PPI refractoriness. PPIs mainly act by improving chemical clearance, i.e., by an antireflux action supporting long-term prescription in PPI-responsive EoE.
- Published
- 2019
- Full Text
- View/download PDF
7. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.
- Author
-
Frazzoni M, Frazzoni L, Tolone S, De Bortoli N, Savarino V, and Savarino E
- Subjects
- Drug Resistance, Electric Impedance, Endoscopy, Gastrointestinal, Esophageal pH Monitoring, Female, Gastroesophageal Reflux complications, Gastroesophageal Reflux diagnosis, Heartburn diagnosis, Heartburn etiology, Humans, Hydrogen-Ion Concentration, Male, Middle Aged, Prospective Studies, Proton Pump Inhibitors therapeutic use, Treatment Outcome, Gastroesophageal Reflux drug therapy, Heartburn drug therapy, Proton Pump Inhibitors pharmacology
- Abstract
Objective: Heartburn is the most specific symptom of reflux disease and is highly responsive to proton pump inhibitor (PPI) therapy. Some patients do not respond to PPIs, but mechanisms of refractoriness have not yet been fully elucidated. Impedance-pH monitoring, allowing comprehensive on-therapy assessment of reflux, represents a valuable test to investigate PPI refractoriness., Methods: Prospective multicenter study comparing endoscopy-negative patients with PPI-refractory and PPI-responsive heartburn. Reflux disease was demonstrated by off-PPI impedance-pH monitoring and mechanisms of refractoriness were studied with on-PPI impedance-pH monitoring. Assessment of impedance-pH tracings comprised conventional parameters, post-reflux swallow-induced peristaltic wave (PSPW) index, and mean nocturnal baseline impedance (MNBI)., Results: Sixty-four patients entered the study, 32 with PPI-refractory and 32 with PPI-responsive heartburn. On PPI, median percentage gastric and esophageal acid exposure time and number of acid refluxes did not differ between the two groups; conversely, number of total and weakly acidic refluxes and percentage bolus exposure were significantly higher while PSPW index and MNBI were significantly lower in PPI-refractory cases. At multivariate logistic regression analysis, PSPW index was the sole independent risk factor for PPI refractoriness (OR 1.082, 95% CI 1.022-1.146, P = 0.007). Comparing off- and on-PPI parameters, median PSPW index did not change in PPI-refractory patients (24% vs. 26%, P = 0.327) but increased significantly in PPI-responsive cases (29% vs. 46%, P < 0.001)., Conclusions: Lack of improvement of impaired chemical clearance is a major determinant of PPI refractoriness. Timely post-reflux salivary swallowing represents a key defensive mechanism and a potential target for future treatment modalities in PPI-refractory reflux-related heartburn.
- Published
- 2018
- Full Text
- View/download PDF
8. Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.
- Author
-
de Bortoli N, Frazzoni L, Savarino EV, Frazzoni M, Martinucci I, Jania A, Tolone S, Scagliarini M, Bellini M, Marabotto E, Furnari M, Bodini G, Russo S, Bertani L, Natali V, Fuccio L, Savarino V, Blandizzi C, and Marchi S
- Subjects
- Adult, Colonoscopy, Esophageal Diseases epidemiology, Esophageal Diseases physiopathology, Esophageal pH Monitoring, Esophagoscopy, Feces chemistry, Female, Gastroesophageal Reflux physiopathology, Heartburn physiopathology, Humans, Irritable Bowel Syndrome metabolism, Irritable Bowel Syndrome physiopathology, Leukocyte L1 Antigen Complex metabolism, Logistic Models, Male, Middle Aged, Multivariate Analysis, Prevalence, Risk Factors, Surveys and Questionnaires, Anxiety epidemiology, Depression epidemiology, Gastroesophageal Reflux epidemiology, Heartburn epidemiology, Irritable Bowel Syndrome epidemiology
- Abstract
Objectives: We aimed to evaluate the prevalence of irritable bowel syndrome (IBS) in patients with typical reflux symptoms as distinguished into gastroesophageal reflux disease (GERD), hypersensitive esophagus (HE), and functional heartburn (FH) by means of endoscopy and multichannel intraluminal impedance (MII)-pH monitoring. The secondary aim was to detect pathophysiological and clinical differences between different sub-groups of patients with heartburn., Methods: Patients underwent a structured interview based on questionnaires for GERD, IBS, anxiety, and depression. Off-therapy upper-gastrointestinal (GI) endoscopy and 24 h MII-pH monitoring were performed in all cases. In patients with IBS, fecal calprotectin was measured and colonoscopy was scheduled for values >100 mg/kg to exclude organic disease. Multivariate logistic regression analysis was performed to identify independent risk factors for FH., Results: Of the 697 consecutive heartburn patients who entered the study, 454 (65%) had reflux-related heartburn (GERD+HE), whereas 243 (35%) had FH. IBS was found in 147/454 (33%) GERD/HE but in 187/243 (77%) FH patients (P<0.001). At multivariate analysis, IBS and anxiety were independent risk factors for FH in comparison with reflux-related heartburn (GERD+HE)., Conclusions: IBS overlaps more frequently with FH than with GERD and HE, suggesting common pathways and treatment. HE showed intermediate characteristic between GERD and FH.
- Published
- 2016
- Full Text
- View/download PDF
9. Microscopic Esophagitis, Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave in Functional Heartburn: Useful Diagnostic Tools.
- Author
-
Furnari M, Tolone S, and de Bortoli N
- Subjects
- Esophageal pH Monitoring, Esophagitis, Esophagitis, Peptic, Gastroesophageal Reflux, Humans, Peristalsis, Electric Impedance, Heartburn
- Published
- 2016
- Full Text
- View/download PDF
10. Data on Symptom Association Analysis in Patients Undergoing Endoscopic Therapy Is Useful to Better Define a Successful Therapeutic Approach.
- Author
-
Tolone S, Furnari M, de Bortoli N, and Savarino E
- Subjects
- Humans, Fundoplication methods, Gastroesophageal Reflux drug therapy, Gastroesophageal Reflux surgery, Proton Pump Inhibitors therapeutic use
- Published
- 2015
- Full Text
- View/download PDF
11. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
- Author
-
de Bortoli N, Leonardi G, Ciancia E, Merlo A, Bellini M, Costa F, Mumolo MG, Ricchiuti A, Cristiani F, Santi S, Rossi M, and Marchi S
- Subjects
- Amoxicillin therapeutic use, Anti-Bacterial Agents therapeutic use, Anti-Ulcer Agents therapeutic use, Breath Tests, Clarithromycin therapeutic use, Drug Therapy, Combination, Endoscopy, Gastrointestinal, Esomeprazole therapeutic use, Female, Humans, Male, Middle Aged, Prospective Studies, Treatment Outcome, Helicobacter Infections drug therapy, Helicobacter pylori, Lactoferrin therapeutic use, Probiotics therapeutic use
- Abstract
Objectives: Helicobacter pylori is causally associated with gastritis and peptic ulcer diseases. Recent data (meta-analysis) have demonstrated that triple therapy with amoxicillin, clarithromycin, and a proton pump inhibitor has an eradication rate of only 74-76% and new therapeutic protocols may be necessary. The aim of this study was to examine whether adding bovine lactoferrin (bLf) and probiotics (Pbs) to the standard triple therapy for H. pylori infection could improve the eradication rate and reduce side effects., Methods: H. pylori infection was diagnosed in 206 patients: in 107 based on an upper endoscopy exam and a rapid urease test, and in 99 by means of the H. pylori stool antigen-test and the C(13) urea breath test (C(13) UBT). The patients were randomized into two groups: 101 patients (group A) underwent standard triple eradication therapy (esomeprazole, clarithromycin, amoxicillin), while 105 patients (group B) underwent a modified eradication therapy (standard triple eradication therapy plus bLf and Pb). Successful eradication therapy was defined as a negative C(13) UBT 8 wk after completion of the treatment. Results were evaluated by intention-to-treat (ITT) and per-protocol (PP) analysis. Data were evaluated and considered positive when P<0.05., Results: At the end of the study 175/206 patients showed negative C(13) UBT results. According to intention-to-treat analysis, the infection was eradicated in 73/101 patients from Group A and in 93/105 from Group B. PP analysis showed 73/96 patients from Group A and 93/101 from Group B to have been successfully treated. More patients from group A than from group B reported side effects from their treatment (P<0.05)., Conclusions: The results of our study suggest that the addition of bLf and Pbs could improve the standard eradication therapy for H. pylori infection--bLf serving to increase the eradication rate and Pbs to reduce the side effects of antibiotic therapy.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.